Related references
Note: Only part of the references are listed.Hydroxyzine, a First Generation H1-Receptor Antagonist, Inhibits Human Ether-a-go-go-Related Gene (HERG) Current and Causes Syncope in a Patient With the HERG Mutation
Tomoko Sakaguchi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes
Annukka Lehtonen et al.
HEART RHYTHM (2007)
N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome
Seiko Ohno et al.
HEART RHYTHM (2007)
New mechanism contributing to drug-induced arrhythmia - Rescue of a misprocessed LQT3 mutant
K Liu et al.
CIRCULATION (2005)
Restricting excessive cardiac action potential and QT prolongation -: A vital role for IKs in human ventricular muscle
N Jost et al.
CIRCULATION (2005)
Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG
K Hayashi et al.
CLINICAL SCIENCE (2004)
A common antitussive drug, clobutinol, precipitates the long QT syndrome 2
C Bellocq et al.
MOLECULAR PHARMACOLOGY (2004)
Drug-induced Long-QT syndrome associated with a subclinical SCN5A mutation
N Makita et al.
CIRCULATION (2002)
Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia
I Splawski et al.
SCIENCE (2002)
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes
P Yang et al.
CIRCULATION (2002)
Cellular consequences of HERG mutations in the long QT syndrome: precursors to sudden cardiac death
CE Clancy et al.
CARDIOVASCULAR RESEARCH (2001)
Inhibition of HERG potassium channel current by the Class 1a antiarrhythmic agent disopyramide
AA Paul et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
A common polymorphism associated with antibiotic-induced cardiac arrhythmia
F Sesti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications - Report on a Policy Conference of the European Society of cardiology
W Haverkamp et al.
EUROPEAN HEART JOURNAL (2000)
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias
C Napolitano et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2000)
Share Paper
